Stock RGEN REPLIGEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Repligen Corporation

Equities

RGEN

US7599161095

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
166.6 USD +0.56% Intraday chart for Repligen Corporation +6.01% -7.35%
04-08 RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating MT
03-20 Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. RGEN Stock
  4. Revisions Repligen Corporation